Now that the Rangers are “out” on re-signing Vladimir Guerrero there have been conflicting reports about his chances of returning to the Angels, but yesterday manager Mike Scioscia indicated during a radio interview that it remains a possibility:
Well, Vladdy’s been one of the guys obviously we’ve talked about for a while, and I think it’s the same situation. Vlad signed with the Rangers before last season because he was looking for a multi-year deal, a big deal at the time. We had to make a decision.
There was no way to commit to three or four years with Vlad, that we could go that route. If it is the same situation right now, obviously, nothing much would change, but he’s definitely a guy that’s very interesting to look at. I just don’t know if that extended deal is out there that he was looking for last year, a three- or four-year deal.
In other words, if he wants to accept a one-year deal the Angels could be interested. If not, they won’t be.
Scioscia talking about Guerrero looking for big multi-year deals is odd, because last offseason he managed only a one-year, $6.5 million contract with the Rangers and there’s little to suggest he’s capable of getting a bigger offer this winter. There are limited suitors for a 36-year-old designated hitter who looked absolutely brutal in his few appearances as an outfielder, particularly with the Rangers dropping out, and Guerrero followed up a poor second half by hitting .220 with zero homers and a 16/2 K/BB ratio in 15 playoff games.
If the Angels are interested and have $5 million to spare, they can probably make a reunion happen.
Things have gone from bad to worse for Red Sox’ outfielder Brock Holt, who was shut down “for the foreseeable future” on Friday after meeting with head trauma specialist Michael Collins. The Red Sox placed Holt on the 10-day disabled list in April after he began experiencing vertigo, the latest in a series of head injuries he’s sustained since last spring.
According to the Boston Herald’s Jason Mastrodonato, the outfielder was initially advised to attempt playing through his symptoms, but it quickly became apparent that the strategy wasn’t going to work. Now, the plan is to shut him down from any game activity in the hopes that he’ll be able to recover from all lingering symptoms before returning to the roster. Club manager John Farrell told reporters that the 28-year-old is still cleared to take batting practice and work on his defense, but won’t continue his rehab starts in Triple-A Pawtucket for the time being.
Holt had been making regular appearances for the Pawtucket Red Sox and was batting .209/.292/.372 with two home runs through 14 games this spring. This season marks his fifth run within the Red Sox’ organization. He experienced a bit of a slump at the plate in 2016 and slashed .255/.322/.383 after breaking out during his first All-Star year in 2015.
Pete Abraham of the Boston Globe suggests that the team’s concern for Holt extends past his setbacks at the plate. It’s still a long road to a full recovery, and while Farrell told reporters he believes the outfielder is on track to make a return sometime in 2017, he’ll need to make sure that Holt is both physically and mentally prepared to do so.
The Washington Nationals have acquired outfielder Ryan Raburn from the Chicago White Sox. Raburn had been playing at Triple-A Charlotte. He’ll be assigned to Triple-A Syracuse in the Nats organization. The Nationals will send cash or a player to be named later to the White Sox to complete the deal.
Raburn has yet to play in the majors this season. Last year he hit .220/.309/.404 with nine homers in 113 games for the Colorado Rockies. The year before that he hit an excellent .301/.393/.543 in part time play for the Indians. Over the course of his 11 year career the 36-year-old has hit .253/.317/.436, which breaks down to an OPS+ of exactly 100, which is league average. Primarily an outfielder, Raburn has played every position except shortstop and catcher in his career. He’s even pitched twice.
The Nats plans for him aren’t entirely clear, but depth it depth.